daunorubicin has been researched along with Cancer of Pancreas in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 7 (41.18) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Błasiak, P; Kulbacka, J; Mączyńska, J; Michel, O; Rossowska, J; Rzechonek, A; Saczko, J | 1 |
| Borska, S; Chmielewska, M; Dziegiel, P; Sopel, M; Zabel, M | 1 |
| Borska, S; Drag-Zalesinska, M; Dumanska, M; Dziegiel, P; Sopel, M; Wysocka, T; Zabel, M | 1 |
| Malerczyk, C; Maser, E; Möller, A; Stöppler, H; Völker, U | 1 |
| Dietel, M; Lage, H | 1 |
| Lage, H; Nieth, C; Priebsch, A; Stege, A | 1 |
| Caldera, H; Cardenas, R; Casillas, J; Servin-Abad, L | 1 |
| Aneja, R; Chandra, R; Joshi, HC; Lage, H; Liu, M; Zhou, J | 1 |
| Hungerer, C; Koch, L; Maser, E; Plebuch, M; Soldan, M | 1 |
| Dietel, M; Holm, PS; Scanlon, KJ | 1 |
| Maser, E; Netter, KJ; Soldan, M | 1 |
| Maser, E; Soldan, M | 1 |
| Koch, L; Maser, E; Soldan, M | 1 |
| Maser, E; Möller, A; Soldan, M; Völker, U | 1 |
| Cheng, E; Chuang, YJ; Niedzwiecki, D; Sordillo, PP; Sternberg, CN | 1 |
| Cheng, EW; Hollander, P; Magill, GB; Sternberg, CN | 1 |
| Cheng, EW; Magill, GB; Mittelman, A; Raymond, V; Sordillo, PB; Sternberg, CN; Young, CW | 1 |
1 review(s) available for daunorubicin and Cancer of Pancreas
| Article | Year |
|---|---|
Granulocytic sarcoma of the pancreas. A report of one case and review of the literature.
Topics: Adult; Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Gemtuzumab; Humans; Male; Middle Aged; Pancreatic Neoplasms; Sarcoma, Myeloid; Tomography, X-Ray Computed | 2003 |
16 other study(ies) available for daunorubicin and Cancer of Pancreas
| Article | Year |
|---|---|
Electroporation with Cisplatin against Metastatic Pancreatic Cancer:
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Survival; Cisplatin; Daunorubicin; Electrochemotherapy; Electroporation; Humans; Pancreatic Neoplasms; Primary Cell Culture | 2018 |
Quercetin as a potential modulator of P-glycoprotein expression and function in cells of human pancreatic carcinoma line resistant to daunorubicin.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Death; Cell Line, Tumor; Cell Membrane; Daunorubicin; Drug Resistance, Neoplasm; Fluoresceins; Gene Expression Regulation, Neoplastic; Humans; Pancreatic Neoplasms; Quercetin | 2010 |
Antiproliferative and pro-apoptotic effects of quercetin on human pancreatic carcinoma cell lines EPP85-181P and EPP85-181RDB.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Cell Line, Tumor; Cell Proliferation; Daunorubicin; DNA Damage; Drug Therapy, Combination; Humans; In Situ Nick-End Labeling; Pancreatic Neoplasms; Quercetin | 2010 |
Monitoring daunorubicin-induced alterations in protein expression in pancreas carcinoma cells by two-dimensional gel electrophoresis.
Topics: Antibiotics, Antineoplastic; Blotting, Western; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Daunorubicin; DNA Damage; Drug Resistance, Neoplasm; Electrophoresis, Gel, Two-Dimensional; Gene Expression; Humans; Pancreatic Neoplasms; Signal Transduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Up-Regulation | 2002 |
Multiple mechanisms confer different drug-resistant phenotypes in pancreatic carcinoma cells.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Survival; Daunorubicin; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Humans; Kinetics; Mitoxantrone; Pancreatic Neoplasms; Phenotype; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 2002 |
Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi).
Topics: Carcinoma; Daunorubicin; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Pancreatic Neoplasms; Phenotype; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Stomach Neoplasms; Tumor Cells, Cultured | 2003 |
Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase.
Topics: Adenoviridae; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Daunorubicin; Down-Regulation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; JNK Mitogen-Activated Protein Kinases; Pancreatic Neoplasms; RNA, Messenger; Stomach Neoplasms | 2006 |
Increased resistance of tumor cells to daunorubicin after transfection of cDNAs coding for anthracycline inactivating enzymes.
Topics: Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductases; Antibiotics, Antineoplastic; Cell Line, Tumor; Cloning, Molecular; Daunorubicin; DNA, Complementary; Drug Resistance; Humans; Inhibitory Concentration 50; Pancreatic Neoplasms; Tetrazolium Salts; Thiazoles; Transfection | 2007 |
Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Carrier Proteins; Cell Division; Cell Line, Transformed; Clone Cells; Codon; Daunorubicin; Drug Resistance; Gene Expression; Humans; Immunohistochemistry; Membrane Glycoproteins; Molecular Sequence Data; Nucleic Acid Conformation; Pancreatic Neoplasms; RNA, Catalytic; RNA, Messenger; Substrate Specificity; Tumor Cells, Cultured | 1994 |
Induction of daunorubicin carbonyl reducing enzymes by daunorubicin in sensitive and resistant pancreas carcinoma cells.
Topics: Alcohol Oxidoreductases; Antineoplastic Agents; Benzaldehydes; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Enzyme Induction; Humans; Metyrapone; Pancreatic Neoplasms; Subcellular Fractions; Tumor Cells, Cultured | 1996 |
Metabolic inactivation and efflux of daunorubicin as complementary mechanisms in tumor cell resistance.
Topics: Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biotransformation; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Isoenzymes; Models, Biological; Oxidoreductases; Pancreatic Neoplasms; Quercetin; Rutin; Transcription, Genetic; Tumor Cells, Cultured | 1997 |
Alterations in the expression of daunorubicin phase-I metabolising enzymes in different carcinoma cell lines.
Topics: Alcohol Oxidoreductases; Aldehyde Reductase; Aldo-Keto Reductases; Antibiotics, Antineoplastic; Daunorubicin; Drug Resistance, Neoplasm; Gene Expression Regulation, Enzymologic; Humans; Neoplasms; Oxidoreductases; Pancreatic Neoplasms; Tumor Cells, Cultured | 1999 |
Two-dimensional gel electrophoresis: a powerful method to elucidate cellular responses to toxic compounds.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Daunorubicin; DNA Primers; Dose-Response Relationship, Drug; Electrophoresis, Gel, Two-Dimensional; Pancreatic Neoplasms; Proteome; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Toxicity Tests; Tumor Cells, Cultured; Up-Regulation | 2001 |
Evaluation of new anticancer agents against human pancreatic carcinomas in nude mice.
Topics: Adult; Aged; Alkaloids; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Intraductal, Noninfiltrating; Daunorubicin; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Male; Menogaril; Mice; Mice, Nude; Microtubules; Neoplasm Transplantation; Nogalamycin; Paclitaxel; Pancreatic Neoplasms; Random Allocation; Transplantation, Heterologous | 1987 |
Phase II trial of menogarol in the treatment of advanced adenocarcinoma of the pancreas.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Daunorubicin; Drug Evaluation; Female; Humans; Male; Menogaril; Middle Aged; Nogalamycin; Pancreatic Neoplasms | 1988 |
Phase II trial of idarubicin in patients with pancreatic cancer.
Topics: Adult; Aged; Daunorubicin; Drug Evaluation; Female; Humans; Idarubicin; Male; Middle Aged; Pancreatic Neoplasms | 1987 |